Author:
Walker Venexia M.,Davies Neil M.,Kehoe Patrick G.,Martin Richard M.
Funder
Perros Trust
MRC University of Bristol Integrative Epidemiology Unit
Sigmund Gestetner Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cognitive Neuroscience,Clinical Neurology,Neurology
Reference37 articles.
1. British National Formulary (BNF). Section 4.11: drugs for dementia. London: BNF; 2015.
https://www.medicinescomplete.com/mc/bnflegacy/current/PHP3236-dementia.htm
. Accessed 11 Jan 2016
2. Donegan K, Fox N, Black N, Livingston G, Banerjee S, Burns A. Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study. Lancet Public Health. 2017;2:e149–56.
3. Mukadam N, Livingston G, Rantell K, Rickman S. Diagnostic rates and treatment of dementia before and after launch of a national dementia policy: an observational study using English national databases. BMJ Open. 2014;4:e004119.
4. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
5. National Institute for Health and Care Excellence (NICE). NICE consults on revised first draft guidance on the use of drugs to treat Alzheimer’s disease (including a review of existing guidance no. 19) [press release].
https://www.nice.org.uk/guidance/TA111/documents/2006001-nice-consults-on-revised-first-draft-guidance-on-the-use-of-drugs-to-treat-alzheimers-disease2
. Accessed 24 Nov 2016.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献